AL
AGN

Aspiriant LLC’s Allergan plc AGN Stock Holding History

Aspiriant LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,362
Closed -$229K – 265
2018
Q1 		$229K Buy
+1,362
New +$228K 0.02% 223
2017
Q4 		– Sell
-5,486
Closed -$1.12M – 197
2017
Q3 		$1.12M Sell
5,486
-399
-7% -$92.8K 0.09% 102
2017
Q2 		$1.43M Sell
5,885
-757
-11% -$178K 0.12% 91
2017
Q1 		$1.59M Buy
6,642
+813
+14% +$189K 0.14% 94
2016
Q4 		$1.22M Sell
5,829
-2,937
-34% -$608K 0.11% 97
2016
Q3 		$2.02M Buy
+8,766
New +$2.14M 0.2% 69

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Aspiriant LLC's AGN Position: Q2 2018 in Review

Aspiriant LLC sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 1,362 shares — an estimated $229K sold.

Aspiriant LLC first reported a position in AGN in Q3 2016 and held it in 6 quarters. The position peaked at $2.02M in Q3 2016. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Aspiriant LLC reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Aspiriant LLC sold 1,362 Allergan plc shares in Q2 2018, an estimated $229K.
  • Aspiriant LLC first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
  • Aspiriant LLC's Allergan plc position peaked at $2.02M in Q3 2016.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Aspiriant LLC's 13F filing for Q2 2018, filed 7 Aug 2018.